The role of leptin in non-alcoholic fatty liver disease

Saudi Journal of Gastroenterology

Volumn 12, Issue 2, 2006, Pages 68-72

  Elbadawy, Reda Amar ^a   Eleter, Eman A ^b   Helmy, Ahmed ^c   Al Ghamdi, Abdalla S ^b   Al Mofleh, Ibrahim ^b   Al Faleh, Faleh Z ^b   Al Freihi, Hussain ^b   Al Amri, Saleh ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Leptin; NAFLD

Indexed keywords

EID: 34948854259     PISSN: 13193767     EISSN: None     Source Type: Journal    
DOI: 10.4103/1319-3767.27848     Document Type: Article

References (35)

1. Brunt EM. Non alcoholic steatohepatitis: definition and pathology. Semin liver Dis 2001; 21: 3-16.
2. Patton HM, Behling C, Patel K. Steatosis in chronic hepatitis C. Hepatology 2002; 36: 349 (abstract).
3. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri B. Non alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-1109.
4. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 2002; 36: 729-736.
5. Czaja AJ, Carpenter HA, Santrach PJ, Moore B. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998; 29: 198-206.
6. Hourigan LF, Macdonald GA, Purdie D, Whitehall V, Shorthouse C, Clouston A. Fibrosis in chronic hepatitis C correlates with body mass index and steatosis. Hepatology 1999; 29: 1215-1219.
7. Petrik J, Guella L, Wight DG, Pearson G, Hinton J, Parker H. Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus. Gut 1998; 42: 103-106.
8. Adinolfi LE, Gambardella M, Andreana A, Tripodi M, Utili. Steatosis accelerates the progression of liver damage of chronic hepatitis C and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-1364.
9. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 1997; 25: 735-739.
10. Adinolfi LE, Utili R, Ruggiero G. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients. Hepatology 1999; 30: 1530.
11. Jonsson JR, Hourigan LF, Purdie D. Body composition and hepatic steatosis as precursor of fibrosis in chronic hepatitis C patients. Hepatology 1999; 30: 1530-1531.
12. Testa R, Franceschini R, Giannini E, Cataldi A, Botta F, Fasoli A et al. Serum leptin levels in patients with chronic viral hepatitis or liver cirrhosis. J Hepatol 2000; 33: 33-37.
13. Potter JJ, Womack L, Mezey E, Anania F. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998; 244: 178-82.
14. Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002; 36: 403-409.
15. Saxena NK, Ikeda K, Rockey DC, Friedman S, Anania F et al. Leptin in hepatic fibrosis; Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002; 35: 762-767.
16. Brunt EM. Non alcoholic steatohepatitis: Definition and pathology. Semin Liver Dis 2001; 21: 3-16.
17. Friedman JM, Halaas JL. Leptin and the regrulation of body weight in mammals. Nature 1998; 395: 3633-3670.
18. Kaplan LM. Leptin obesity and liver disease. Gastroenterology 1998; 115: 997-1001.
19. Treiber G, Csepregi A, Klauck S, Simple, low-cast, and noninvasive quantification of steatosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2005; 128 (suppl 2): A-543.
20. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri R, Bacon B et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
21. Romero-Gomez M, Castellano B, Grand L, Irles J, Cruz M, Nogales M et al. Serum leptin level correlate with hepatocyte steatosis in chronic hepatitis C. Am J Gastroenterol 2003; 98: 1135-1141.
22. Couillard C, Mauriege P, Prud'homme D, Nadeau A, Tremblay A, Bauchard C et al. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 1997; 40: 1178-84.
23. Hui JM, Kench J, Farrell GC, Lin R, Samarasinghe D, Liddle C et al. Genotype specific mechanisms for hepatic steatosis in chronic hepatitis C infection. J Gastroenteral Hepatol 2002; 17: 873-881.
24. Uygun A, Kadayifci A, Yesilova Z, Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000; 95: 3584-3589.
25. Ockenga J, Bischoff SC, Tillmann HL, Erdil A, Yaman H, Saka M et al. Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2000; 119: 1656-1662.
26. Considine RV, Sinha MK, Heiman ML. Serum immunoreactive J Hepatol 2001; 34: 314-320.
27. Cohen B, Novick D, Rubinstein M. Modulation of insuline by leptin. Science 1996; 274: 1185-1188.
28. Paradis V, Mathurin P, Kollinger M. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 1997; 50: 401-406.
29. Roden M, Anderwald C, Furnsinn C, Lvaldhausl W, Lohninger A. Effects of shortterm leptin exposure on triglyceride deposition in rat liver. Hepatology 2000; 32: 1045-1049.
30. Powell EE, Edwards-Smith CJ, Hay JL. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828-833.
31. Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura Tm Takei Y. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001; 34: 288-297.
32. Faggioni R, Jones-Carson J, Reed DA, Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci USA 2000; 97: 2367-2372.
33. Widjaja A, Wedemeyer H, Tillmann HL, Dinarello C, Freingold K, Gronfeld. Hepatitis C and the leptin system: bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy. Scand J Gastroenterol 2001; 36: 426-431.
34. Clouston AD, Jonsson JR, Purdie DM, Macdonald G, Pendeya N, Shorthouse et al. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol 2001; 34: 314-320.
35. Garwieh S, Rodo B, Lindor M. Adipokine levels are predictive of histology in patients with NASH. Hepatology 2004; 40: 237A (abstract).